Prosensa to Present at Upcoming Investor Conferences

Prosensa Holding B.V. Logo

Leiden, The Netherlands, March 6, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) announced today announced presentations at upcoming investor conferences. Celia Economides, Senior Director, Investor Relations & Corporate Communications, will present a corporate overview at the ROTH Conference 2014 in Dana Point, California on Tuesday, March 11, at 10:30am (Pacific Time) and at the Barclays Healthcare Conference in Miami, Florida on Wednesday, March 12, at 1:30pm (Eastern Time).

Live webcasts can be accessed through the Investors & Media section of the Prosensa corporate website at and will be archived for 90 days.

About Prosensa Holding N.V.

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.

CONTACT: Prosensa Holding N.V. Celia Economides, Senior Director IR & Corporate Communications Phone: +1 917 941 9059 Email:

Source:Prosensa Holding N.V.